Ono Pharmaceutical (OTCMKTS:OPHLF) Share Price Passes Above 50-Day Moving Average – Time to Sell?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF)’s stock price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $10.49 and traded as high as $10.51. Ono Pharmaceutical shares last traded at $10.51, with a volume of 1,647 shares.

Ono Pharmaceutical Stock Down 4.5 %

The company’s 50-day moving average is $10.49 and its two-hundred day moving average is $12.61. The company has a market cap of $4.94 billion, a P/E ratio of 7.87 and a beta of 0.59.

Ono Pharmaceutical (OTCMKTS:OPHLF) last released its earnings results on Thursday, October 31st. The company reported $0.24 earnings per share for the quarter. Ono Pharmaceutical had a net margin of 19.64% and a return on equity of 11.80%. The firm had revenue of $824.42 million during the quarter.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.